Prelude Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,500
Closed -$252K 1711
2022
Q2
$252K Buy
+1,500
New +$322K 0.01% 1152
2021
Q2
Sell
-6,000
Closed -$1.13M 1770
2021
Q1
$1.13M Sell
6,000
-1,000
-14% -$176K 0.03% 550
2020
Q4
$1.15M Sell
7,000
-1,000
-13% -$146K 0.03% 433
2020
Q3
$997K Buy
+8,000
New +$990K 0.05% 275

Other funds holding HCA

Prelude Capital Management's HCA Position: Q1 2026 in Review

Prelude Capital Management increased its HCA Healthcare (HCA) stake by 22% in Q1 2026, buying an estimated $108K and bringing the position to 1,186 shares worth $561K. The position accounts for 0.04% of the portfolio, ranked #465.

Prelude Capital Management first reported a position in HCA in Q2 2013 and has held it in 39 quarters since. The position peaked at $8.8M in Q4 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Prelude Capital Management held 1,186 shares of HCA Healthcare worth $561K as of Q1 2026.
  • Prelude Capital Management bought 214 HCA Healthcare shares in Q1 2026, an estimated $108K.
  • HCA Healthcare made up 0.04% of Prelude Capital Management's portfolio in Q1 2026, its #465 holding.
  • Prelude Capital Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 39 quarters since.
  • Prelude Capital Management's HCA Healthcare position peaked at $8.8M in Q4 2023.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.